BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Press Releases

  Quebec’s Committee on Immunization (CIQ) recommends use of RSV vaccines, including AREXVY, for older adult populations at risk of severe outcomes

  July 24, 2024

   · 

  4 min read
• 

  Series A

  J&J Alums Raise $165M Series A for Startup to Develop Biologics for Cancer, Autoimmune Diseases

  Third Arc Bio, led by three former Johnson & Johnson executives, is advancing a portfolio of multifunctional antibodies for cancer and inflammatory and immune-mediated diseases.

  July 24, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Pharmacy benefit managers

  PBM Execs Point Fingers at Pharma Industry in House Hearing on Rising Drug Prices

  Executives from the three largest pharmacy benefit manager companies testified Tuesday before Congress that rising drug prices in the U.S. are due to pharma companies taking advantage of market exclusivities and excessive charges.

  July 24, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  Alterity Therapeutics to Present at MST Financial Webinar

  July 24, 2024

   · 

  1 min read
• Press Releases

  Beacon Biosignals Announces Strategic Collaboration with Skye Bioscience to Integrate Sleep Quality and Sleep Apnea Endpoints in CBEYOND™ Phase 2 Trial of Nimacimab for Obesity

  July 24, 2024

   · 

  4 min read
• Press Releases

  Emergent BioSolutions Launches Opioid Emergency Preparedness ‘Lay, Spray, Stay’ Public Education Campaign Starring Pro Football Hall of Famer Emmitt Smith

  July 24, 2024

   · 

  7 min read
• Press Releases

  Notable Labs Receives FDA Clearance to Proceed Further with Volasertib Phase 2 Study

  July 24, 2024

   · 

  8 min read
• Press Releases

  Beyond “One Bug, One Drug” - Tonix Pharmaceuticals Secures Up To $34 Million In Funding From The U.S. Department Of Defense To Develop a Broad-Spectrum Antiviral

  July 24, 2024

   · 

  6 min read
• Press Releases

  SoniVie announces advancements in its renal denervation program: REDUCED-1 pilot study results, radial access First-In-Human results, and FDA pivotal IDE approval of The THRIVE global study

  July 24, 2024

   · 

  3 min read
• Press Releases

  Advarra Brings Together Clinical Trial Patient Recruitment Activities to Centralize Visibility and Accelerate Enrollment

  July 24, 2024

   · 

  4 min read